Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/1995
10/18/1995EP0677114A1 Recombinant swinepox virus
10/18/1995EP0677113A1 Viral amplification of recombinant messenger rna in transgenic plants
10/18/1995EP0677112A1 Method for obtaining transgenic plants showing a modified fructan pattern
10/18/1995EP0677110A1 Recombinant lactic acid bacterium containing an inserted promoter and method of constructing same
10/18/1995EP0677109A1 Expression system for producing apolipoprotein ai-m
10/18/1995EP0677108A1 Method for breeding disease resistance into plants
10/18/1995EP0677107A1 Clotting inhibitor made from protostomia saliva.
10/18/1995EP0677106A1 Leukocyte derived growth factors
10/18/1995EP0677105A1 Allergenic proteins and peptides from dog dander and uses therefor
10/18/1995EP0677104A1 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use
10/18/1995EP0677103A1 Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament
10/18/1995EP0677100A1 Method for production of neuroblasts
10/18/1995EP0677099A1 Enhancer sequence for modulating expression in epithelial cells
10/18/1995EP0677063A1 A NEW CLASS OF RPTPases: THEIR STRUCTURAL DOMAINS AND LIGANDS
10/18/1995EP0677057A1 Biopolymer synthesis utilizing surface activated, organic polymers
10/18/1995EP0677055A1 Antisense molecules directed against a fibroflast growth factor receptor gene family
10/18/1995EP0677053A1 Enhanced yeast expression using regulatory control sequences from yeast sorbitol dehydrogenase gene
10/18/1995EP0676966A1 Antibodies directed against binding-associated epitopes
10/18/1995EP0676965A1 Compounds having reduced immunogenicity and a method of reducing the immunogenicity of compounds
10/18/1995EP0676955A1 Red blood cell surrogate
10/18/1995EP0676954A1 Human immunodeficiency virus decoy
10/18/1995EP0555203B1 Expression induction method employing dhfr gene
10/18/1995EP0541704A4 Assay, methods and products based on -i(n) k?+ channel expression
10/18/1995EP0291533B1 Rna ribozyme restriction endoribonucleases and methods
10/18/1995CN1110323A Novel polypeptides and DNAS encoding them
10/18/1995CN1110320A Method and device for conversion of plant
10/18/1995CN1110319A Method for preparation of human interleukin-6 and its products
10/18/1995CN1110177A Materials and methods for immunocontraception
10/17/1995US5459255 For incorporation into oligonucleotides, cleaving RNA site specifically
10/17/1995US5459253 M-RNA purification
10/17/1995US5459252 Root specific gene promoter
10/17/1995US5459251 And a polynucleotide comprising the same that is expressed or replicated in bacteria
10/17/1995US5459250 Truncated mammalian growth factor DNA sequence
10/17/1995US5459235 Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils
10/17/1995US5459128 Restenosis inhibitors
10/17/1995US5459127 Cationic lipids for intracellular delivery of biologically active molecules
10/17/1995US5459072 DNA sequences on chromosomes and plasmids from microorganisms
10/17/1995US5459064 Derived from bacillus licheniformis, encoded by specified, purified dna sequences and cleaves peptide bonds
10/17/1995US5459063 Antimalarial agents
10/17/1995US5459055 Thermostable ribonuclease H isolated from Thermus flavus
10/17/1995US5459052 Method of producing IGF-1
10/17/1995US5459051 Genetic engineering, gene expression
10/17/1995US5459049 Gastrointestinal disorders
10/17/1995US5459047 BMP-6 proteins
10/17/1995US5459046 Cytochrome C gene derived from hydrogen bacterium
10/17/1995US5459043 Hybridoma CT43 producing a monoclonal antibody to a novel mucin epitope which correlates with the presence of colorectal cancer
10/17/1995US5459039 Methods for mapping genetic mutations
10/17/1995US5459037 Electrophoresis, change in RNA expression due to drugs, physiological or pathological conditions
10/17/1995US5459036 Extracellular signal-regulated kinase, sequences, and methods of production and use
10/17/1995US5459034 Difficile specific oligonucleotides
10/17/1995US5459015 High-affinity RNA ligands of basic fibroblast growth factor
10/17/1995US5458878 P. exotoxin fusio proteins have COOHG220101al alterations which increase cytotoxicity
10/17/1995US5458874 Method of increasing monocyte chemotaxis with CAP37 and monocyte chemotactic portions thereof
10/17/1995CA2011020C Compositions and protocols applicable to genetic analysis
10/17/1995CA1337336C Human papillomavirus nucleic acid hybridization probes and methods for employing the same
10/12/1995WO1995027080A2 Dna sequencing by stepwise ligation and cleavage
10/12/1995WO1995027079A2 Method for reducing background signals in dna replication/detection assays
10/12/1995WO1995027071A2 An adenovirus supervector system
10/12/1995WO1995027070A1 Dna expression vectors for use in the treatment of vascular diseases by gene therapy
10/12/1995WO1995027069A1 Alphavirus rna as carrier for vaccines
10/12/1995WO1995027068A1 Reduction of endogenous seed protein levels in plants
10/12/1995WO1995027067A1 Purified dna polymerase from bacillus stearothermophilus
10/12/1995WO1995027066A2 Dna encoding ubiquitin conjugating enzymes
10/12/1995WO1995027065A1 Method for selecting transformed eucaryotic cells and cells obtained thereby
10/12/1995WO1995027064A1 Ethanol production by transformation of gram-positive microbes
10/12/1995WO1995027063A2 Rfb retrovirus genome
10/12/1995WO1995027062A1 Agonist antibodies against the flk2/flt3 receptor and uses thereof
10/12/1995WO1995027061A1 Protein tyrosine kinase agonist antibodies
10/12/1995WO1995027060A2 Biologically active eph family ligands
10/12/1995WO1995027059A1 Afamin: a human serum albumin-like protein
10/12/1995WO1995027058A1 MOLECULAR CLONING AND EXPRESSION OF A η-INTERFERON INDUCIBLE ACTIVATOR OF THE PROTEASOME
10/12/1995WO1995027057A1 GENE CODING FOR IgG-Fc-BINDING PROTEIN
10/12/1995WO1995027056A1 Parasite immunoglobulin binding proteins, and their use as vaccines
10/12/1995WO1995027055A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY
10/12/1995WO1995027054A1 Use of dna oligomers for inhibition of hiv by decreasing ribosomal frameshifting
10/12/1995WO1995027053A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING CHYMASE INHIBITING ACTIVITY
10/12/1995WO1995027052A1 Human interleukin variants generated by alternative splicing
10/12/1995WO1995027051A1 Modified gad, a method for manufacturing of modified gad and a method to supply modified gad and peptide
10/12/1995WO1995027049A1 High-alkaline protease and its use
10/12/1995WO1995027047A2 Highly-purified recombinant reverse transcriptase
10/12/1995WO1995027046A2 Enzymatic antimicrobial compositions containing haloperoxidases
10/12/1995WO1995027045A1 The isolation and production of catalytic antibodies using phage technology
10/12/1995WO1995027044A1 ALPHAVIRUS cDNA VECTORS
10/12/1995WO1995027043A1 Antibacterial therapy with genotypically modified bacteriophage
10/12/1995WO1995026986A1 Monoclonal antibody to oncofetal protein for treating and detecting cancer
10/12/1995WO1995026982A2 Malaria peptides
10/12/1995WO1995026973A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects
10/12/1995WO1995026751A1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF CANINE HERPESVIRUS gB, gC and gD AND USES THEREFOR
10/12/1995WO1995026747A1 Prophenins - antibiotic peptides
10/12/1995WO1995026746A1 Compositions and methods for stimulating megakaryocyte growth and differentiation
10/12/1995WO1995026733A1 Oligonucleoside cleavage compounds and therapies
10/12/1995WO1995026718A1 Compositions and methods for delivery of genetic material
10/12/1995WO1995026634A1 Nematicidal proteins
10/12/1995WO1995026628A1 Regeneration of green plants from protoplasts isolated from microspore cultures of barley
10/12/1995WO1995024928A3 Heparin-binding growth factors for gene therapy and anterior eye disorders
10/12/1995WO1995019443A3 Chemically regulatable and anti-pathogenic dna sequences and uses thereof
10/12/1995WO1995006743A3 Methods and compositions for the large scale production of recombinant adeno-associated virus
10/12/1995DE4411718A1 RFB-Retrovirusgenom RFB retrovirus genome
10/12/1995CA2187170A1 Method for selecting transformed eucaryotic cells and cells obtained thereby
10/12/1995CA2187167A1 Biologically active eph family ligands
1 ... 3739 3740 3741 3742 3743 3744 3745 3746 3747 3748 3749 3750 3751 3752 3753 3754 3755 3756 3757 3758 3759 ... 4023